Reaction Details |
| Report a problem with these data |
Target | Neuropeptide Y receptor type 2 |
---|
Ligand | BDBM44012 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | Fluorescence-based counterscreen for agonists of NPY-Y1: cell-based high-throughput dose response assay for agonists of NPY-Y2. |
---|
EC50 | 22680±n/a nM |
---|
Citation | PubChem, PC Fluorescence-based counterscreen for agonists of NPY-Y1: cell-based high-throughput dose response assay for agonists of NPY-Y2. PubChem Bioassay(2009)[AID] |
---|
More Info.: | Get all data from this article, Solution Info, Assay Method |
---|
|
Neuropeptide Y receptor type 2 |
---|
Name: | Neuropeptide Y receptor type 2 |
Synonyms: | NPY-Y2 | NPY-Y2 receptor | NPY2-R | NPY2R | NPY2R_HUMAN | Neuropeptide Y receptor type 2 | Y2 receptor | neuropeptide Y receptor Y2 |
Type: | Enzyme Catalytic Domain |
Mol. Mass.: | 42734.65 |
Organism: | Homo sapiens (Human) |
Description: | NPY-Y2 NPY2R HUMAN::P49146 |
Residue: | 381 |
Sequence: | MGPIGAEADENQTVEEMKVEQYGPQTTPRGELVPDPEPELIDSTKLIEVQVVLILAYCSI
ILLGVIGNSLVIHVVIKFKSMRTVTNFFIANLAVADLLVNTLCLPFTLTYTLMGEWKMGP
VLCHLVPYAQGLAVQVSTITLTVIALDRHRCIVYHLESKISKRISFLIIGLAWGISALLA
SPLAIFREYSLIEIIPDFEIVACTEKWPGEEKSIYGTVYSLSSLLILYVLPLGIISFSYT
RIWSKLKNHVSPGAANDHYHQRRQKTTKMLVCVVVVFAVSWLPLHAFQLAVDIDSQVLDL
KEYKLIFTVFHIIAMCSTFANPLLYGWMNSNYRKAFLSAFRCEQRLDAIHSEVSVTFKAK
KNLEVRKNSGPNDSFTEATNV
|
|
|
BDBM44012 |
---|
n/a |
---|
Name | BDBM44012 |
Synonyms: | 2-(1,3-benzothiazol-2-yl)-2-(5-chloranyl-1-ethyl-3-nitro-6-oxidanylidene-pyridazin-4-yl)ethanenitrile | 2-(1,3-benzothiazol-2-yl)-2-(5-chloro-1-ethyl-3-nitro-6-oxo-4-pyridazinyl)acetonitrile | 2-(1,3-benzothiazol-2-yl)-2-(5-chloro-1-ethyl-3-nitro-6-oxopyridazin-4-yl)acetonitrile | 2-(1,3-benzothiazol-2-yl)-2-(5-chloro-1-ethyl-6-keto-3-nitro-pyridazin-4-yl)acetonitrile | MLS000564980 | SMR000152203 | cid_3641052 |
Type | Small organic molecule |
Emp. Form. | C15H10ClN5O3S |
Mol. Mass. | 375.79 |
SMILES | CCn1nc(c(C(C#N)c2nc3ccccc3s2)c(Cl)c1=O)[N+]([O-])=O |
Structure |
|